Participant flow30

How many started, completed or left each group, period by period.

1 to 20 of 30

Period	Milestone	Group	Participants
Overall Study	STARTED	SLE- Placebo	5
Overall Study	STARTED	SLE- Branebrutinib	15
Overall Study	STARTED	pSS- Placebo	4
Overall Study	STARTED	pSS- Branebrutinib	10
Overall Study	STARTED	RA- Placebo	21
Overall Study	STARTED	RA- Branebrutinib	64
Overall Study	Double Blind Period	SLE- Placebo	5
Overall Study	Double Blind Period	SLE- Branebrutinib	15
Overall Study	Double Blind Period	pSS- Placebo	4
Overall Study	Double Blind Period	pSS- Branebrutinib	10
Overall Study	Double Blind Period	RA- Placebo	21
Overall Study	Double Blind Period	RA- Branebrutinib	64
Overall Study	Open Label Period	SLE- Placebo	0
Overall Study	Open Label Period	SLE- Branebrutinib	0
Overall Study	Open Label Period	pSS- Placebo	0
Overall Study	Open Label Period	pSS- Branebrutinib	0
Overall Study	Open Label Period	RA- Placebo	20
Overall Study	Open Label Period	RA- Branebrutinib	61
Overall Study	COMPLETED	SLE- Placebo	3
Overall Study	COMPLETED	SLE- Branebrutinib	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04186871/flow